Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Therapeutic Vaccines Market Research Report by Vaccines Type, Disease Indication, Administration,...
-
NEW YORK, Aug. 23, 2022 (GLOBE NEWSWIRE) -- After successfully completing in vitro and in vivo (mice) experiments, which support the notion that its lead drug candidate OM-301 breaks down cancer...
-
Las Vegas, USA, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Global Human Papillomavirus Associated Cancer Pipeline Insight | Clinical Trials Research Report 2022 by DelveInsight Human Papillomavirus...
-
Dublin, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The "Devic's Syndrome Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
-
Transferred anti-IL 18 monoclonal antibody product (AVTX-007) to Apollo Therapeutics in July with the approximate $15 million of upfront payment received in AugustDosed first patient in the Phase 2...
-
Avalo to receive an approximately $15 million upfront payment, up to $74 million in milestone payments.Apollo to lead continued clinical development of AVTX-007, currently in Phase 1b ROCKVILLE, Md....
-
Proven Biotech Executive Brings Versatile Leadership Experience MARIETTA, Ga., July 18, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational...
-
Seattle, July 12, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global adult vaccines market is estimated to be valued at US$ 16,790.11 million in 2022 and is expected to...
-
Las Vegas, USA, June 20, 2022 (GLOBE NEWSWIRE) -- Global Food Allergy Pipeline Insight | Clinical Trials Evaluation Research Report 2022 by DelveInsight Food Allergy Pipeline constitutes 35+...
-
New York, June 20, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Therapeutic Vaccines Market Research Report by Vaccines Type, Disease Indication, Administration,...